| 000 | 01554 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515050117.0 | ||
| 264 | 0 | _c20080514 | |
| 008 | 200805s 0 0 chi d | ||
| 022 | _a1673-4254 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKang, Hua-feng | |
| 245 | 0 | 0 |
_a[Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism]. _h[electronic resource] |
| 260 |
_bNan fang yi ke da xue xue bao = Journal of Southern Medical University _cNov 2006 |
||
| 300 |
_a1599-602 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a9,10-Dimethyl-1,2-benzanthracene |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCelecoxib |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xchemically induced |
| 650 | 0 | 4 |
_aPyrazoles _xtherapeutic use |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
| 650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 700 | 1 | _aWang, Xi-jing | |
| 700 | 1 | _aLiu, Xiao-xu | |
| 700 | 1 | _aDai, Zhi-jun | |
| 700 | 1 | _aXue, Feng-jie | |
| 700 | 1 | _aXue, Xing-huan | |
| 773 | 0 |
_tNan fang yi ke da xue xue bao = Journal of Southern Medical University _gvol. 26 _gno. 11 _gp. 1599-602 |
|
| 999 |
_c16693125 _d16693125 |
||